A phase 2 study of RG7906 (RO6889450) for the treatment of psychiatric disorders
Latest Information Update: 13 Feb 2019
At a glance
- Drugs Ralmitaront (Primary)
- Indications Psychiatric disorders
- Focus Therapeutic Use
Most Recent Events
- 13 Feb 2019 New trial record